Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP for Acute Decompensated Heart Failure (Ningdu County People's Hospital)
ChiCTR2600116781Phase 4Not yet recruiting
- Sponsor
- Ningdu County People's Hospital
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nesiritide in Acute Heart Failure (AHF) (2 arms), sponsored by Ningdu County People's Hospital. Primary endpoints: NT-proBNP absolute level and Percentage change in NT-proBNP versus baseline between groups. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2600116781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116781.